Prostate Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age >= 18 years old, male; 2.Preoperatively, the diagnosis of prostate adenocarcinoma was confirmed by pathology, and a radical prostatectomy was planned. 3.Before the operation, complete clinical data were available, including serum prostate-specific antigen (PSA), imaging data (such as MRI, ultrasound), and physical examination records, etc. 4.Participating in the preoperative and postoperative follow-up, and being able to accept the quality of life questionnaire and functional assessment; 5.Have the ability to sign the informed consent form and voluntarily participate in this study.
Exclusion criteria
Exclusion criteria: 1.Patients with a confirmed diagnosis of advanced or metastatic prostate cancer; 2.Patients who have previously received prostate cancer–related treatments (e.g., endocrine therapy, radiotherapy, surgery); 3.Patients with severe organ dysfunction, immune system diseases, or psychiatric disorders that contraindicate study participation; 4.Patients with incomplete data or unavailable imaging studies or biological samples; 5.Patients unwilling or unable to comply with study follow-up and data collection.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intraoperative and postoperative complications;Postoperative Functional Recovery;Intraoperative blood loss;Duration of the surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Intraoperative Pneumoperitoneum Stability; | — |
Countries
China
Contacts
Zhejiang Provincial People's Hospital